We have been collecting data on the adverse effects of chemotherapy in our hospital and analysing it, and based on our analysis of adverse effect data for acute myelogenous leukemia patients, we prepared a brochure entitled “Explanation of the adverse effects of high dose Ara-C chemotherapy”. We then used a questionnaire to ascertain patients' impressions of our brochure. From the results, we noted that it could reduce the anxiety that patients felt towards the chemotherapy and enabled them to prepare themselves for the adverse effects. We are sure that this kind of activity will help us to provide better pharmaceutical care for patients.
